Sökning: "BCP-ALL"
Visar resultat 6 - 10 av 14 avhandlingar innehållade ordet BCP-ALL.
6. Identification and evaluation of novel prognostic genetic markers for childhood acute lymphoblastic leukemia
Sammanfattning : Childhood acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer today. Due to advances in risk stratification and treatment, survival rates have increased drastically the last decades. Currently, children with acute leukemia in the Nordic countries are diagnosed and treated according to the NOPHO-2008 treatment protocol. LÄS MER
7. Molecular studies of prognostic and etiological factors in childhood leukemia
Sammanfattning : Acute lymphoblastic leukemia (ALL) is the most common cancer in childhood. It is caused by the somatic acquisition of genetic abnormalities and malignant transformation of immature lymphocytes in the bone marrow, most commonly of B-cell lineage. LÄS MER
8. Molecular Interrogation and Functional Studies of Acute Leukemia
Sammanfattning : Hematological malignancies are defined by their underlying genetic alterations, many of which are used to diagnose patients to classify them to different risk groups that dictate the therapy given. Recent advances in high-throughput sequencing have highlighted the presence of co-occurring genetic lesions and that they may form distinct genetic clones that evolve throughout disease progression. LÄS MER
9. Prognostic molecular markers of childhood leukemia
Sammanfattning : During the last decades there has been a dramatic increase in survival rates for childhood leukemia, resulting today in an overall survival close to 90 % for children with acute lymphoblastic leukemia (ALL). This accomplishment is largely due to treatment protocols based on careful risk group assessment guiding the type and intensity of the anti-leukemic treatment. LÄS MER
10. Minimal Residual Disease Assessment in Childhood Acute Lymphoblastic Leukemia
Sammanfattning : Traditionally, response to treatment in hematological malignancies is evaluated by light microscopy of bone marrow (BM) smears, but due to more effective therapies more sensitive methods are needed. Today, detection of minimal residual disease (MRD) using immunological and molecular techniques can be 100 times more sensitive than morphology. LÄS MER